Dn B Asset Management As Ngm Biopharmaceuticals Inc Transaction History
Dn B Asset Management As
- $19.9 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding NGM
# of Institutions
5Shares Held
2.6MCall Options Held
300Put Options Held
0About NGM BIOPHARMACEUTICALS INC
- Ticker NGM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,365,904
- Description
- NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...